GLOPERBA Drug Patent Profile
✉ Email this page to a colleague
When do Gloperba patents expire, and what generic alternatives are available?
Gloperba is a drug marketed by Scilex Pharms and is included in one NDA. There are four patents protecting this drug and one Paragraph IV challenge.
This drug has three patent family members in two countries.
The generic ingredient in GLOPERBA is colchicine. There are sixteen drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the colchicine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Gloperba
A generic version of GLOPERBA was approved as colchicine by AMNEAL PHARMS on September 28th, 2016.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GLOPERBA?
- What are the global sales for GLOPERBA?
- What is Average Wholesale Price for GLOPERBA?
Summary for GLOPERBA
International Patents: | 3 |
US Patents: | 4 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 113 |
Clinical Trials: | 1 |
Patent Applications: | 4,100 |
Drug Prices: | Drug price information for GLOPERBA |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for GLOPERBA |
What excipients (inactive ingredients) are in GLOPERBA? | GLOPERBA excipients list |
DailyMed Link: | GLOPERBA at DailyMed |
Recent Clinical Trials for GLOPERBA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Helwan University | Phase 3 |
Pharmacology for GLOPERBA
Drug Class | Alkaloid |
Paragraph IV (Patent) Challenges for GLOPERBA
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
GLOPERBA | Oral Solution | colchicine | 0.6 mg/5 mL | 210942 | 1 | 2020-04-02 |
US Patents and Regulatory Information for GLOPERBA
GLOPERBA is protected by four US patents.
Patents protecting GLOPERBA
Colchicine drug-to-drug interactions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Colchicine drug-to-drug interactions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: A METHOD OF PROPHYLACTIC TREATMENT OF GOUT FLARES IN ADULTS COMPRISES ADMINISTERING TO A PATIENT A LIQUID COLCHICINE ORAL SOLUTION
Colchicine drug-to-drug interactions
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Composition and method of use of colchicine oral liquid
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scilex Pharms | GLOPERBA | colchicine | SOLUTION;ORAL | 210942-001 | Jan 30, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Scilex Pharms | GLOPERBA | colchicine | SOLUTION;ORAL | 210942-001 | Jan 30, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Scilex Pharms | GLOPERBA | colchicine | SOLUTION;ORAL | 210942-001 | Jan 30, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Scilex Pharms | GLOPERBA | colchicine | SOLUTION;ORAL | 210942-001 | Jan 30, 2019 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for GLOPERBA
See the table below for patents covering GLOPERBA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
World Intellectual Property Organization (WIPO) | 2017156392 | ⤷ Sign Up | |
European Patent Office | 3426227 | COMPOSITION ET MÉTHODE D'UTILISATION DE LIQUIDE ORAL DE COLCHICINE (COMPOSITION AND METHOD OF USE OF COLCHICINE ORAL LIQUID) | ⤷ Sign Up |
World Intellectual Property Organization (WIPO) | 2019126579 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |